7Baggers
 brokerages set gain therapeutics, inc. (nasdaq:ganx) pt at $8.00  Defense World Sat, 27 Sep 2025 05:39:36 GMT
 Tackling Parkinson’s Disease With Allosteric Modulators  Technology Networks Fri, 26 Sep 2025 11:12:14 GMT
 published on: 2025-09-22 12:08:47  newser.com Mon, 22 Sep 2025 17:08:47 GMT
 published on: 2025-09-22 11:59:13  newser.com Mon, 22 Sep 2025 16:59:13 GMT
 best momentum stocks to buy for january 9th  MSN Fri, 19 Sep 2025 21:00:04 GMT
 gain therapeutics extends phase 1b parkinson’s treatment study  Investing.com India Fri, 19 Sep 2025 09:29:06 GMT
 Gain Therapeutics extends Phase 1b Parkinson’s treatment study  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 14:43:05  خودرو بانک Tue, 16 Sep 2025 11:14:11 GMT
 published on: 2025-09-13 16:50:18  newser.com Sat, 13 Sep 2025 21:50:18 GMT
 gain therapeutics' (ganx) buy rating reiterated at btig research  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 published on: 2025-09-11 19:40:47  Newser Fri, 12 Sep 2025 00:40:47 GMT
 gain therapeutics (nasdaq:ganx) given buy rating at btig research  MarketBeat Wed, 10 Sep 2025 12:56:23 GMT
 gain therapeutics' (ganx) buy rating reiterated at btig research  MarketBeat Wed, 10 Sep 2025 12:56:23 GMT
 gain therapeutics (nasdaq:ganx) receives buy rating from btig research  Defense World Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 20:10:41  Newser Tue, 09 Sep 2025 01:10:41 GMT
 published on: 2025-09-08 14:24:03  Newser Mon, 08 Sep 2025 19:24:03 GMT
 published on: 2025-09-08 02:26:41  Newser Mon, 08 Sep 2025 07:26:41 GMT

Gain Therapeutics, Inc
(NASDAQ:GANX) 

GANX stock logo

Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...

Founded: 2017
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends